Keros Therapeutics, Inc. KROS
9.50 USD +0.32 (+3.54%)
Nov 10, 2026, 10:09 AM EST
9.20 Day range 9.48
9.10 52-week range 22.55
- YTD
- -53.36%
- 1 year
- -44.28%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 244.06M | 3.55M | 151.00K | 0 | 20.10M | |
| 244.06M | 3.55M | 151.00K | 0 | 20.10M | |
| 244.06M | 3.55M | 151.00K | 0 | 20.10M | |
| 176.49M | 214.38M | 170.09M | 114.79M | 76.47M | |
| 129.64M | 173.63M | 135.26M | 87.27M | 55.14M | |
| 46.85M | 40.75M | 34.83M | 27.52M | 21.33M | |
| 67.57M | -210.83M | -169.94M | -114.79M | -56.37M | |
| 4.88M | 300.00K | 0 | 0 | 2.01M | |
| 87.01M | -187.35M | -152.99M | -104.68M | -58.74M | |
| 87.01M | -187.35M | -152.99M | -104.68M | -58.74M | |
| 87.01M | -187.35M | -152.99M | -104.68M | -58.74M | |
| 87.01M | -187.35M | -152.99M | -104.68M | -58.74M | |
| 2.34 | -5.00 | -5.20 | -4.15 | -2.52 | |
| 2.34 | -5.00 | -5.20 | -4.15 | -2.52 | |
| 2.30 | -5.00 | -5.20 | -4.15 | -2.52 | |
| 91.90M | -187.05M | -152.99M | -104.68M | -56.73M | |
| 91.90M | -187.05M | -152.99M | -104.68M | -56.73M | |
| 37.22M | 37.44M | 29.45M | 25.24M | 23.33M | |
| 37.86M | 37.44M | 29.45M | 25.24M | 23.33M |